Unusual presentation of COVID-19 in a child complicated by massive acute pulmonary embolism and lung infarction

The Novel Coronavirus 2019 (SARSCoV- 2), which was first reported on in Wuhan, China, in late December 2019, causes a respiratory illness called COVID- 19 Disease. COVID-19 is most likely causing a hypercoagulable state, however the prevalence of acute venothromboembolism is still unknown. Limited d...

Descripción completa

Detalles Bibliográficos
Autores principales: Bin Ali, Tahani, Elyamany, Ghaleb, Nojoom, Maha, Alfaki, Mohamed, Alahmari, Hassan, Alharthi, Abdulwahab, Hijazi, Muwaffak, Alsahari, Atif, Alabbas, Fahad, Al-Otaibi, Abdulnasir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970399/
https://www.ncbi.nlm.nih.gov/pubmed/33747414
http://dx.doi.org/10.4081/hr.2021.8874
Descripción
Sumario:The Novel Coronavirus 2019 (SARSCoV- 2), which was first reported on in Wuhan, China, in late December 2019, causes a respiratory illness called COVID- 19 Disease. COVID-19 is most likely causing a hypercoagulable state, however the prevalence of acute venothromboembolism is still unknown. Limited data suggest pulmonary microvascular thrombosis may play a role in progressive respiratory failure. Here, we report a case of a child with an unusual presentation of COVID-19 presented initially by dry cough without fever and complicated by massive acute pulmonary embolism and lung infarction and treated successfully by hydroxychloroquine and azithromycin, in addition to anticoagulant therapy.

Ejemplares similares